- Home
- NMRA vs REFI Comparison
NMRA vs REFI Comparison
Compare NMRA & REFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NMRA | REFI |
|---|---|---|
| Founded | 2019 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Real Estate Investment Trusts |
| Sector | | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 302.0M | 257.7M |
| IPO Year | 2023 | 2021 |
Fundamental Metrics
Financial Performance| Metric | NMRA | REFI |
|---|---|---|
| Price | $0.48 | $8.80 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 5 |
| Target Price | $6.14 | ★ $15.13 |
| AVG Volume (30 Days) | ★ 2.2M | 188.8K |
| Earning Date | 11-05-2026 | 11-03-2026 |
| Dividend Yield | N/A | ★ 20.19% |
| EPS Growth | ★ 5.23 | N/A |
| EPS | N/A | ★ 0.57 |
| Revenue | N/A | ★ $48,857,628.00 |
| Revenue This Year | N/A | $0.76 |
| Revenue Next Year | N/A | $7.89 |
| P/E Ratio | ★ N/A | $16.35 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.32 | $9.04 |
| 52 Week High | $3.65 | $13.49 |
Technical Indicators
Market Signals| Indicator | NMRA | REFI |
|---|---|---|
| Relative Strength Index (RSI) | 32.74 | 23.41 |
| Support Level | N/A | N/A |
| Resistance Level | $1.72 | $10.97 |
| Average True Range (ATR) | 0.06 | 0.26 |
| MACD | 0.02 | -0.08 |
| Stochastic Oscillator | 40.59 | 0.00 |
Price Performance
Historical ComparisonAbout NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.
About REFI Chicago Atlantic Real Estate Finance Inc.
Chicago Atlantic Real Estate Finance Inc is engaged in a commercial real estate finance company. The Company operates as one operating segment, and its primary investment objective is to provide attractive, risk-adjusted returns for stockholders over time, mainly through consistent current income (dividends and distributions) and secondarily, through capital appreciation. The company operates mainly within the USA itself.